エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/08 | 7,394 | 7,466 | 7,370 | 7,405 | +54 | +0.7% | 757,800 |
2018/05/07 | 7,408 | 7,420 | 7,206 | 7,351 | -90 | -1.2% | 775,400 |
2018/05/02 | 7,407 | 7,442 | 7,297 | 7,441 | +12 | +0.2% | 820,200 |
2018/05/01 | 7,322 | 7,432 | 7,307 | 7,429 | +84 | +1.1% | 666,400 |
2018/04/27 | 7,350 | 7,360 | 7,270 | 7,345 | +57 | +0.8% | 748,300 |
2018/04/26 | 7,345 | 7,350 | 7,255 | 7,288 | -76 | -1% | 865,200 |
2018/04/25 | 7,167 | 7,420 | 7,128 | 7,364 | +226 | +3.2% | 1,251,500 |
2018/04/24 | 7,194 | 7,194 | 7,110 | 7,138 | -13 | -0.2% | 717,300 |
2018/04/23 | 7,123 | 7,160 | 7,096 | 7,151 | +77 | +1.1% | 693,100 |
2018/04/20 | 7,078 | 7,142 | 7,031 | 7,074 | -19 | -0.3% | 803,700 |
2018/04/19 | 7,059 | 7,110 | 7,053 | 7,093 | +51 | +0.7% | 880,100 |
2018/04/18 | 6,965 | 7,076 | 6,955 | 7,042 | +69 | +1% | 912,600 |
2018/04/17 | 6,881 | 6,998 | 6,881 | 6,973 | +57 | +0.8% | 807,800 |
2018/04/16 | 6,851 | 6,921 | 6,821 | 6,916 | +80 | +1.2% | 524,900 |
2018/04/13 | 6,888 | 6,889 | 6,791 | 6,836 | -3 | ±0% | 922,500 |
2018/04/12 | 6,650 | 6,853 | 6,630 | 6,839 | +158 | +2.4% | 1,017,400 |
2018/04/11 | 6,801 | 6,843 | 6,653 | 6,681 | -207 | -3% | 1,252,400 |
2018/04/10 | 7,060 | 7,094 | 6,862 | 6,888 | -167 | -2.4% | 1,175,500 |
2018/04/09 | 6,967 | 7,081 | 6,939 | 7,055 | +89 | +1.3% | 721,300 |
2018/04/06 | 7,001 | 7,028 | 6,880 | 6,966 | -71 | -1% | 1,049,700 |
2018/04/05 | 6,908 | 7,075 | 6,879 | 7,037 | +242 | +3.6% | 1,454,700 |
2018/04/04 | 6,843 | 6,869 | 6,768 | 6,795 | -19 | -0.3% | 952,500 |
2018/04/03 | 6,753 | 6,850 | 6,711 | 6,814 | -12 | -0.2% | 936,900 |
2018/04/02 | 6,779 | 6,915 | 6,743 | 6,826 | +45 | +0.7% | 859,400 |
2018/03/30 | 6,837 | 6,837 | 6,728 | 6,781 | -5 | -0.1% | 677,500 |
2018/03/29 | 6,804 | 6,898 | 6,739 | 6,786 | +39 | +0.6% | 1,196,900 |
2018/03/28 | 6,643 | 6,753 | 6,632 | 6,747 | -19 | -0.3% | 982,900 |
2018/03/27 | 6,710 | 6,771 | 6,644 | 6,766 | +80 | +1.2% | 1,078,000 |
2018/03/26 | 6,566 | 6,695 | 6,554 | 6,686 | +93 | +1.4% | 1,189,000 |
2018/03/23 | 6,636 | 6,750 | 6,589 | 6,593 | -243 | -3.6% | 1,800,900 |
2018/03/22 | 6,780 | 6,842 | 6,753 | 6,836 | +28 | +0.4% | 1,224,300 |
2018/03/20 | 6,885 | 6,935 | 6,784 | 6,808 | -130 | -1.9% | 1,166,200 |
2018/03/19 | 6,890 | 6,968 | 6,869 | 6,938 | -2 | ±0% | 853,200 |
2018/03/16 | 6,917 | 6,968 | 6,887 | 6,940 | +58 | +0.8% | 1,287,300 |
2018/03/15 | 6,912 | 6,938 | 6,831 | 6,882 | +4 | +0.1% | 1,000,700 |
2018/03/14 | 6,908 | 6,985 | 6,842 | 6,878 | -51 | -0.7% | 1,433,300 |
2018/03/13 | 6,750 | 6,932 | 6,745 | 6,929 | +143 | +2.1% | 1,875,700 |
2018/03/12 | 6,608 | 6,805 | 6,572 | 6,786 | +478 | +7.6% | 3,292,600 |
2018/03/09 | 6,187 | 6,430 | 6,172 | 6,308 | +182 | +3% | 3,552,300 |
2018/03/08 | 6,177 | 6,177 | 5,982 | 6,126 | +549 | +9.8% | 3,299,200 |
2018/03/07 | 5,582 | 5,649 | 5,565 | 5,577 | -37 | -0.7% | 1,065,500 |
2018/03/06 | 5,613 | 5,675 | 5,598 | 5,614 | +54 | +1% | 897,200 |
2018/03/05 | 5,571 | 5,630 | 5,526 | 5,560 | ±0 | ±0% | 1,301,800 |
2018/03/02 | 5,560 | 5,591 | 5,534 | 5,560 | -93 | -1.6% | 1,180,000 |
2018/03/01 | 5,664 | 5,682 | 5,625 | 5,653 | -43 | -0.8% | 918,600 |
2018/02/28 | 5,702 | 5,748 | 5,696 | 5,696 | -74 | -1.3% | 903,300 |
2018/02/27 | 5,782 | 5,834 | 5,743 | 5,770 | +24 | +0.4% | 916,600 |
2018/02/26 | 5,700 | 5,752 | 5,672 | 5,746 | +115 | +2% | 649,300 |
2018/02/23 | 5,576 | 5,640 | 5,565 | 5,631 | +61 | +1.1% | 681,900 |
2018/02/22 | 5,550 | 5,594 | 5,539 | 5,570 | -40 | -0.7% | 861,700 |
1601~
1650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム